Paul Krell
About Paul Krell
Paul Krell serves as the Vice President and General Manager EMEA at Inari Medical, a position he has held since 2024. He has extensive experience in the medical devices industry, with a strong focus on market development and the introduction of new therapies.
Work at Inari Medical
Paul Krell currently serves as the Vice President and General Manager EMEA at Inari Medical, a position he has held since 2024. He is based in Basel, Switzerland. Inari Medical focuses on innovative solutions in the field of medical devices, particularly in the treatment of venous diseases. Krell previously held the role of General Manager EMEA at Inari Medical from 2020 to 2023, where he contributed to the company's growth and market presence in the region.
Previous Experience in Medical Devices
Before joining Inari Medical, Paul Krell held various leadership positions in the medical devices sector. He was Vice President of Sales and Marketing at ev3 Europe from 2004 to 2007 and served as Country Manager for Germany, Austria, and Switzerland from 2002 to 2004. Additionally, he worked as Vice President Europe at Sequent Medical from 2011 to 2018, where he played a significant role in the company's commercial activities, including the acquisition of Sequent Medical for US$ 380 million in 2016.
Education and Expertise
Paul Krell holds an MBA with Honors from IMD, which he completed from 2000 to 2001. He also studied Elektrotechnik at RWTH Aachen University, where he earned his Diplom from 1984 to 1992. His educational background supports his extensive expertise in cardiac rhythm management, cardiac surgery, and neuroradiology. Krell specializes in introducing new therapies and building markets within the medical devices industry.
Background in Market Development
Krell has a strong track record in founding and building European subsidiaries for US companies, focusing on market development and reimbursement applications. His experience spans various roles that emphasize strategic growth and the introduction of innovative medical therapies. This background has equipped him with the skills necessary to navigate the complexities of the European medical device market.